Stay updated on BAT2206 vs Stelara in Psoriasis Clinical Trial
Sign up to get notified when there's something new on the BAT2206 vs Stelara in Psoriasis Clinical Trial page.

Latest updates to the BAT2206 vs Stelara in Psoriasis Clinical Trial page
- Check7 days agoChange DetectedThe Zhejiang University hospital location name was standardized to 'Second Affiliated Hospital, Zhejiang University, School of Medicine' (replacing the previous form). The revision tag was updated from v3.6.4 to v3.6.5.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe page displays an updated revision tag: v3.6.4, replacing the previous v3.6.3. This reflects a small update to the page version without altering study content.SummaryDifference0.1%

- Check28 days agoNo Change Detected
- Check43 days agoChange DetectedThe page shows an updated revision label, moving from v3.6.2 to v3.6.3, indicating a minor software update to the ClinicalTrials.gov interface. This change does not alter study data or visible content.SummaryDifference0.1%

- Check50 days agoChange DetectedThe page revision label was updated from v3.6.0 to v3.6.2, indicating a newer revision of the page rather than a change to study details.SummaryDifference0.1%

- Check64 days agoChange DetectedThe page now indicates that recruitment has ended and adds new help/navigation items (How to Read a Study Record, Common Questions, How to Join a Study), along with minor formatting changes to the Intervention/Treatment label and an updated Revision: v3.6.0.SummaryDifference0.5%

- Check72 days agoChange DetectedThe page revision has been updated from v3.5.4 to v3.5.5, reflecting an administrative update to the page. This change does not alter study details, eligibility, outcomes, or contacts.SummaryDifference0.1%

Stay in the know with updates to BAT2206 vs Stelara in Psoriasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BAT2206 vs Stelara in Psoriasis Clinical Trial page.